Laboratory of Clinical Pathology, "Buccheri La Ferla" Hospital, Palermo, Italy.
Laboratory of Clinical Pathology, "Buccheri La Ferla" Hospital, Palermo, Italy.
Clin Chim Acta. 2019 Jun;493:25-30. doi: 10.1016/j.cca.2019.01.016. Epub 2019 Jan 25.
Identifying the target molecule in food allergies, helps to assess the risk of anaphylaxis in a patient. Lipid Transfer Protein is the most frequent cause of food allergies in the Mediterranean area. The diagnosis based on allergenic extracts, suffers from a high variability in the results because some important allergenic molecules are lacking. This study was disegned to assess whether Pru p 3 and Ara h 9 molecules are quantitative and qualitative enough present in their whole allergenic extracts.
943 patients with a clinical history of suspected peach and/or peanut food allergies were recruited and underwent measurement of a specific serum IgE (ImmunoCAP system (Thermofisher/Phadia Diagnostics, Uppsala, Sweden) to the following allergens and molecules: peach (f95) and/or peanut (f13), Pru p 3 (f420), Pru p 1 (f419), Pru p 4 (f421), Ara h 1 (f422), Ara h 2 (f423) Ara h 3 (f424) and Ara h 9 (f427).
Out of the 943 patients included in this study, 122 were positive to sIgE to peanut extract. At a cut-off point of 0.35 kIU/L, 62 patients were positive to sIgE to Ara h 9 but negative to peanut extract. Increasing the cut-off point of Ara h 9 at 10 kIU/L, 15 patients were only positive to sIgE to Ara h 9. 244 out of the 943 patients were positive to sIgE to peach extract. At a cut-off point of 0.35 kIU/L, 27 patients were negative to sIgE to Pru p 3 and positive to sIgE to peach extract, whilst 11 patients were peach extract sIgE positive and sIgE negative to Pru p 1, Pru p 3 and Pru p 4. Only 12 patients resulted positive to Pru p1 and/or Pru p 4.
Our data strongly suggests to include the measurement of sIgE to Ara h 9 into the diagnostic algorithm of peanut sensitization. 4.5% of the sicilian population suspected of peach sensitization were positive to peach extract and negative to all the available molecules.
鉴定食物过敏中的靶分子有助于评估患者发生过敏反应的风险。脂质转移蛋白是地中海地区食物过敏的最常见原因。基于过敏原提取物的诊断结果存在很大的变异性,因为一些重要的过敏原分子缺失。本研究旨在评估桃和/或花生致敏物中的 Pru p 3 和 Ara h 9 分子是否在其整个过敏原提取物中具有足够的定量和定性。
招募了 943 名有疑似桃和/或花生食物过敏临床病史的患者,并对以下过敏原和分子进行了特异性血清 IgE(免疫捕获系统(Thermofisher/Phadia Diagnostics,Uppsala,瑞典)的测量:桃(f95)和/或花生(f13)、Pru p 3(f420)、Pru p 1(f419)、Pru p 4(f421)、Ara h 1(f422)、Ara h 2(f423)、Ara h 3(f424)和 Ara h 9(f427)。
在本研究纳入的 943 名患者中,有 122 名对花生提取物 sIgE 呈阳性。在 0.35 kIU/L 的截断值下,有 62 名患者对 Ara h 9 的 sIgE 呈阳性,但对花生提取物呈阴性。将 Ara h 9 的截断值提高到 10 kIU/L,有 15 名患者仅对 Ara h 9 的 sIgE 呈阳性。943 名患者中有 244 名对桃提取物 sIgE 呈阳性。在 0.35 kIU/L 的截断值下,有 27 名患者对 Pru p 3 的 sIgE 呈阴性,对桃提取物呈阳性,而 11 名患者对桃提取物 sIgE 呈阳性,对 Pru p 1、Pru p 3 和 Pru p 4 的 sIgE 呈阴性。只有 12 名患者对 Pru p1 和/或 Pru p 4 呈阳性。
我们的数据强烈表明,将 Ara h 9 的 sIgE 测量纳入花生致敏的诊断算法中。西西里岛有 4.5%的疑似桃过敏人群对桃提取物呈阳性,而对所有现有分子均呈阴性。